Psittacosis, also known as parrot fever or ornithosis, is a zoonotic infectious disease caused by the obligate intracellular bacterium Chlamydia psittaci. The disease derives its name from the primary reservoir—psittacine birds such as parrots, parakeets, cockatiels, and budgerigars—though infection has been documented across a broad range of avian species including pigeons, turkeys, chickens, and ducks. The organism establishes infection in birds, many of which may remain asymptomatic while shedding bacteria in feces and respiratory secretions for prolonged periods, creating ongoing environmental contamination that poses transmission risk to humans.
Disease Profile
BacterialPsittacosis
鹦鹉热
Psittacosis is a zoonotic bacterial infection caused by Chlamydia psittaci, primarily transmitted to humans through inhalation of aerosolised bird droppings or respiratory secretions. While many infections present as mild influenza-like illness, the disease can progress to severe atypical pneumonia with systemic complications. Bird-to-human transmission remains the dominant pathway, with psittacine birds and other poultry serving as natural reservoirs. No human vaccine exists, making exposure prevention the cornerstone of public health control.
The clinical spectrum of psittacosis ranges from completely asymptomatic infection to life-threatening atypical pneumonia. The incubation period typically spans 5 to 14 days, though delayed symptom onset has been reported. Most patients present with a characteristic symptom complex including fever, chills, headache, myalgia, and a non-productive cough; some individuals develop progressive shortness of breath indicative of lower respiratory involvement. Less common manifestations include gastrointestinal symptoms, rash, splenomegaly, and pulse-temperature dissociation. Chest imaging typically reveals lobar or interstitial infiltrates in patients with pneumonia. Severe complications, though uncommon, encompass hepatitis, encephalitis, endocarditis, and other neurologic sequelae, underscoring the disease's potential for systemic involvement beyond the respiratory tract.
Psittacosis occurs worldwide wherever humans maintain close contact with infected birds, whether through pet ownership, poultry handling, or occupational exposure in aviculture and veterinary settings. The disease maintains a persistent but typically low-incidence profile in surveillance systems, partly due to diagnostic challenges and underrecognition. Birds serve as the primary reservoir, and infection pressure correlates with environments where aerosolised contaminated dust accumulates—such as poorly ventilated bird housing facilities, pet shops, and poultry processing environments. The absence of person-to-person transmission and the lack of foodborne spread through poultry products limit outbreak amplification, though sporadic cases and occupational clusters continue to be reported in settings with inadequate exposure controls.
Human infection predominantly occurs through inhalation of aerosolised particles containing Chlamydia psittaci, originating from dried bird droppings or respiratory secretions of infected birds. This airborne route accounts for the majority of documented cases and explains the occupational risk to bird handlers, pet shop workers, and poultry industry personnel. Less frequent transmission pathways include direct bird bites and beak-to-mouth contact, though these represent minor contributors to overall disease incidence. Critically, no evidence supports transmission through handling or consuming poultry products, and documented human-to-human spread remains exceedingly rare, suggesting that person-to-person transmission, if it occurs, is epidemiologically insignificant.
Source-backed detail is not yet available.
No licensed human vaccine exists for psittacosis, rendering exposure prevention the sole protective strategy. Public health recommendations emphasize hand hygiene after bird contact, wetting contaminated surfaces before cleaning to prevent aerosol generation, and avoiding dry sweeping or vacuuming of potentially infected material. Personal protective equipment including gloves and appropriate respiratory masks should be worn when handling birds suspected of infection or cleaning their enclosures. Avian control measures complement human prevention efforts and include avoiding bird overcrowding, maintaining physical separation between cages, isolating and treating infected birds, and implementing regular cleaning protocols for cages and feeding implements. These integrated approaches reduce both environmental contamination and human exposure risk.
Psittacosis presents surveillance challenges due to its nonspecific clinical presentation, which mimics other causes of atypical pneumonia including Mycoplasma, Legionella, and viral respiratory infections. Routine microbiologic testing protocols in many clinical settings do not include Chlamydia psittaci screening, contributing to underdiagnosis and incomplete case ascertainment. Diagnosis typically requires specialized testing—serology, polymerase chain reaction assays, or advanced metagenomic sequencing in complex cases—limiting surveillance sensitivity in resource-constrained settings. Clinicians should maintain a high index of suspicion for patients with pneumonia and recent bird exposure history, as targeted diagnostic inquiry can improve case detection. Occupational case clustering around aviculture, pet retail, and poultry processing facilities may signal lapses in exposure control and warrant investigation.
Figure 1 | Full historical trajectories across all reporting countries.
Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.
Dataset Archive
Supplementary Data | Multi-country disease dataset
Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.
Source Register
Official sources and update cadences used to construct the downloadable dataset.
Australia
Australian national notifiable diseases surveillance dashboard.
Official sourceJapan
Japan weekly infectious disease surveillance via NIID/JIHS.
Official sourceUnited States
CDC National Notifiable Diseases Surveillance System provisional data.
Official source